About Haelixa
Haelixa is a company based in Zurich (Switzerland) founded in 2015 was acquired by Clariant in September 2018.. Haelixa has raised $127.51 thousand across 4 funding rounds from investors including Clariant, Zurcher Kantonalbank and European Union. Haelixa offers products and services including DNA Marking Technology. Haelixa operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
- Headquarter Zurich, Switzerland
-
Sectors
HealthcareRetail Energy & Utilities
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Haelixa
Haelixa offers a comprehensive portfolio of products and services, including DNA Marking Technology. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Uses DNA to track and verify material origins in supply chains.
Unlock access to complete
Funding Insights of Haelixa
Haelixa has successfully raised a total of $127.51K across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Last Round
-
First Round
First Round
(09 Jan 2017)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2019 | Amount | Seed - Haelixa | Valuation | Verve Ventures | |
| Sep, 2017 | Amount | Grant - Haelixa | Valuation |
investors |
|
| Jun, 2017 | Amount | Seed - Haelixa | Valuation | Venture Kick |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Haelixa
Haelixa has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Clariant, Zurcher Kantonalbank and European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on science and tech-driven startups
|
Founded Year | Domain | Location | |
|
University backed startup accelerator
|
Founded Year | Domain | Location | |
|
Commercial banking services are provided across Switzerland by Zurcher Kantonalbank.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Haelixa
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Haelixa
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Haelixa Comparisons
Competitors of Haelixa
Haelixa operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
Dental implants and regenerative dentistry products are developed.
|
|
| domain | founded_year | HQ Location |
RNA-editing technologies are provided for precision medicine applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Haelixa
Frequently Asked Questions about Haelixa
When was Haelixa founded?
Haelixa was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Where is Haelixa located?
Haelixa is headquartered in Zurich, Switzerland.
Is Haelixa a funded company?
Haelixa is a funded company, having raised a total of $127.51K across 4 funding rounds to date. The company's 1st funding round was a Seed of $127.51K, raised on Jan 09, 2017.
What does Haelixa do?
Haelixa was founded in 2015 in Zurich, Switzerland. DNA-based tracers are offered for the energy industry, enabling fluid tracking and monitoring of parameters such as temperature, light, pH, and oxidants in subsurface environments. Encapsulated DNA sequences provide unique identification at parts-per-trillion levels, supporting reservoir characterization and product authentication. Operations focus on exploration, quality control, and liability management within harsh conditions.
Who are the top competitors of Haelixa?
Haelixa's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
What products or services does Haelixa offer?
Haelixa offers DNA Marking Technology.
Who are Haelixa's investors?
Haelixa has 5 investors. Key investors include Clariant, Zurcher Kantonalbank, European Union, Verve Ventures, and Venture Kick.